🚨Media Spotlight🚨 We’re excited to share that Tenomix has been featured in two prominent publications! 🎉 1️⃣ Toronto Star: https://lnkd.in/geQaWsU6 2️⃣ Canadian Healthcare Technology Magazine (Page 22): https://lnkd.in/gaR5qmgB We’re honoured to have our work recognized as we strive to bring innovation to healthcare and support clinicians and patients worldwide. Thank you to our collaborators and supporters for being part of this journey! #healthcareinnovation #AIinHealthcare #medtech
CEO, President & Founder at Tenomix Inc. | Entrepreneur | Translational Scientist | Innovator
"How do we better support our clinicians and patients?" This question stays with me every night as I wrap up my work. A recent Ontario study involving 651,071 cancer patients revealed a stark reality: 35.3% visited the emergency department (ED) within 90 days before diagnosis, and over half of these visits led to hospital admission. For many, the ED is a stressful and reactive setting for navigating a potential cancer diagnosis. These patients often face worse outcomes, including late-stage detection and fragmented follow-up care: https://lnkd.in/guzui5u5. The study's findings highlight a pressing issue—our healthcare model is fundamentally flawed. With so many Canadians lacking access to family doctors, early symptom checks and timely specialist referrals are delayed until symptoms worsen. This highlights the urgent need to rethink healthcare as an ecosystem: one that is distributed, preventive, and focused on early intervention, while also supporting patients diagnosed at later stages with the timely care they need. As we work toward rebuilding this infrastructure, innovators like us have a responsibility to collaborate with clinicians to create solutions that offer real utility. At Tenomix Inc., we’re developing automated technologies to save costs, enhance clinical workflows, and empower laboratory staff to reallocate their limited time to other urgent cases coming into the lab. I’m incredibly thankful to Toronto Star, Canadian Healthcare Technology Magazine, and MaRS Discovery District (thank you, Louise Pichette!) for recognizing our work at Tenomix through these recent press releases (see article links further below). Shoutout to the incredible health-tech companies like Oxford Cancer Analytics, Zucara Therapeutics Inc., RetiSpec, MIMOSA Diagnostics, and LINDA, who are also addressing some of the most pressing challenges in healthcare. Together, we’re striving to bring novel AI-driven solutions to life and the support of early adopters, funders, and government stakeholders become vital to our collective success. To our clinical collaborators across Canada and the U.S.—your invaluable support and feedback continue to shape our technology, enabling us to deliver meaningful benefits and ensure seamless integration into real-world workflows. We’re grateful to work alongside you as we aim to transform healthcare. Let’s keep pushing for innovation that empowers healthcare teams, drives preventive care, and, ultimately, improves patient outcomes. If you're interested in reading more, you can access the articles below: - Article 1 - Toronto Star: https://lnkd.in/gsjE-nqQ - Article 2 - Canadian Healthcare Technology Magazine (page 22): https://lnkd.in/gA-MGVy3 #healthcareinnovation #AIinHealthcare #medtech #cancerdiagnosis